On October 12, 2022, the board of directors of Curis, Inc. elected Anne E. Borgman, M.D., to serve as a class I director until the 2024 Annual Meeting of Stockholders and thereafter until her successor is duly elected and qualified. Dr. Borgman will serve on the Nominating and Corporate Governance Committee, effective immediately, until her successor is duly appointed and qualified or until her earlier resignation or removal. Dr. Borgman will receive compensation for her board service as a non-employee director commensurate with the Company's previously-disclosed director compensation program, including a one-time nonqualified stock option under the Fourth Amended and Restated 2010 Stock Incentive Plan to purchase 25,000 shares of the company's common stock with an exercise price equal to the closing price of the company's common stock on the Nasdaq Global Market on the grant date.